Archivo
Seminarios del Área de Oncohematología y Genética
New therapeutic combinations to overcome cisplatin resistance in bladder cancer
Generation of CAR-Tregs for the treatment of Graft versus Host Disease
New genetic approach for sarcoma diagnosis
Nuevas dianas terapéuticas en cáncer colorrectal basadas en letalidad sintética de factores de reparación de daño en el DNA
Pre-emptive eradication of therapy-resistant clones in aggressive prostate cancer
Analysis of Extracellular Vesicles and Soluble Proteins in Cancer Immunomodulation and Liquid Biopsy
¿Cómo llega el conocimiento científico a la sociedad desde el IBiS? Sus implicaciones en la investigación
New aplications of Artificial Intelligence in Dermatology
Structure, function and pharmacology of oncogenic kinases
Estudios Radiobiología 2023
A new treatment for sarcoma extracted from combination of miRNA deregulation and gene association rules
Exosomal microRNAs as immunotherapy biomarkers predicting response to pembrolizumab in Non-Small Cell Lung Cancer
Implementation of a genomic strategy for precision medicine in rare diseases: towards a clinical-genomic integration in an interoperable health system
Ceramide: an essential but mysterious lipid
Mechanistic models-guided drug repurposing in sarcoma
Decoding the Mysteries of RNA Metabolism and Its Role in Genome Stability and Cancer
CANCELADO - Structure, function and pharmacology of oncogenic kinases
The transcription factor Sfp1 imprints specific classes of mRNAs and links their synthesis and cytoplasmic decay
Targeting MCL1 in palbociclib-treated bladder cancer cells
Papel del eje BCL-2 en el desarrollo de enfermedad injerto contra huésped versus injerto contra leucemia postrasplante alogénico
DNA Topoisomerase 1 Promotes DNA Double Strand Breaks Associated to Gene Transcription
Función de VE-Cadherina en el Mimetismo Vasculogénico
DNA Topoisomerase 1 Promotes DNA Double Strand Breaks Associated to Gene Transcription
Identificación del receptor beta de las hormonas tiroideas (THRB) como gen causal en casos dominantes de distrofias hereditarias de retina
Dona
Fomenta la ciencia con una donación y forma parte del cambio.